MedPath

Kamisyoyosan's effects on some menopausal symptoms study:KOSMOS Study

Phase 4
Completed
Conditions
Menopausal disorders
Registration Number
jRCT1080223160
Lead Sponsor
Tsumura & Co.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
Female
Target Recruitment
60
Inclusion Criteria
  1. Menopausal disorder patients
  2. Patients who had mental manifestation.
  3. Patients who had vasomotor sympotms.
  4. Agreement to sign an informed consent.
Exclusion Criteria
  1. Patients with an extremely weak gastrointestinal tract
  2. Patients with anorexia, nausea and vomiting
  3. Patients with severe psychiatric disorder
  4. Patinets with serious complications
  5. Patients who are decided inadequate by their doctor

Study & Design

Study Type
Interventional
Study Design
A randomized double blind, placebo-controlled trial
Primary Outcome Measures
NameTimeMethod
-

safety

efficacy

The change in menopansal symptom (excitement and irritability)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Japan

Location not specified

Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.